Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Chronic inflammatory demyelinating polyradiculoneuropathy(CIDP): Treatment and prognosis].
Successful cyclosporine treatment in 2 patients with refractory CIDP, involving monitoring of both AUC(0-4h) and trough levels.
Demyelinating diseases in Asia.
The need for a disease-specific prospective pregnancy registry for multiple sclerosis (MS).
Clinical perspectives of TRAIL: insights into central nervous system disorders.
Cost-Effectiveness of New Therapies for Multiple Sclerosis In Spain.
Vitamin D Modulates the Expression of IL-27 and IL-33 in the Central Nervous System in Experimental Autoimmune Encephalomyelitis (EAE).
Disruption of estrous cycle homeostasis in mice with experimental autoimmune encephalomyelitis.
Increased expression ratio of matrix metalloproteinase-9 (MMP9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) RNA levels in Iranian multiple sclerosis patients.
T-cell responses to distinct AQP4 peptides in patients with neuromyelitis optica (NMO).
YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis.
Deficiency of NF-kappaB c-Rel Accelerates the Development of Autoimmune Diabetes in Non-Obese Diabetic Mice.
Fatigue and heat sensitivity in patients with multiple sclerosis.
Neuroprotection of Neuro2a cells and the cytokine suppressive and anti-inflammatory mode of action of resveratrol in activated RAW264.7 macrophages and C8-B4 microglia.
Multi-channel registration of fractional anisotropy and T1-weighted images in the presence of atrophy: application to multiple sclerosis.
Impact of Ongoing National Health Technology Assessment Challenges on Patient Access to New Therapies for Multiple Sclerosis In Germany And The Uk.
A systematic review of stress-management interventions for multiple sclerosis patients.
Sex bias in CNS autoimmune disease mediated by androgen control of autoimmune regulator.
Icariin has synergistic effects with methylprednisolone to ameliorate EAE via modulating HPA function, promoting anti-inflammatory and anti-apoptotic effects.
Transdermal immunotherapy: Past, present and future.
Diffusion Weighted MRI Characterization of White Matter Injury Produced by Axon-sparing Demyelination and Severe Contusion Spinal Cord Injury in Rats.
Using A Mixed Methods Approach to Develop A Discrete Choice Experiment In Multiple Sclerosis.
[Protocol for neurophysiological studies of the pelvic floor to appraise anorectal dysfunction in patients with multiple sclerosis].
Fluctuating neurological symptoms in demyelinating disease mimicking an acute ischaemic stroke.
"Her illness is a project we can work on together": developing a collaborative family-centered intervention model for newly diagnosed multiple sclerosis.
Pages
« first
‹ previous
…
716
717
718
719
720
721
722
723
724
…
next ›
last »